Intrinsic immunosuppression underlies the efficacy of the checkpoint inhibitors programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte associated protein 4 (CTLA-4) in many cancer types (37). The gene discussed is CTLA4; the disease is cancer.